Publication | Open Access

The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: A 2-year trial

Bone DiseaseBone HealthHip Structural GeometryMedicineAromatasePharmacotherapyBreast CancerMenopauseAromatase InhibitorsOncologyRadiation OncologyOsteoporosisOrthopaedic Surgery2-Year TrialMenopause Hormone Therapy